VICO — Vicore Pharma Holding AB Share News
0.000.00%
Last trade - 00:00- SEK2.73bn
- SEK1.83bn
- SEK3.82m
Brief: Vicore Pharma: Update On Progress In Clinical Lead Program VP01 (C21)
Brief: Vicore Pharma Changes Listing To Nasdaq Stockholm's Main Market
Brief: Vicore Pharma Establishes Safe And Well-Tolerated Dose Of C21 In Phase I Study
Brief: Vicore Pharma Q2 Operating Loss Widens To SEK 24.8 Mln
Brief: Vicore Pharma Q1 Operating Loss At SEK 16.1 Million
Brief: Vicore Pharma Selects Systemic Sclerosis As Second Indication For Its Lead Program
Brief: Vicore Pharma Q4 Oper Loss Widens To SEK 13.7 Mln; Aims To List On Nasdaq Main List
Brief: Vicore Pharma Resolves On Share Issue Of Around SEK 160 Mln
Brief: Vicore Pharma Resolves On Share Issue Of Around SEK 160 Mln
Brief: Vicore Pharma Q3 Operating Loss Widens To SEK 6.4 Million
Brief: Vicore Pharma: Rights Issue Oversubscribed By 33 Percent
Brief: Vicore Pharma Holding: Carl-Johan Dalsgaard Appointed New CEO Of Vicore Pharma
Brief: Vicore Pharma Appoints Carl-Johan Dalsgaard New CEO
Brief: Vicore Pharma Appoints Carl-Johan Dalsgaard New CEO
Brief: Vicore Pharma April-June Operating Loss Widens To SEK 5.6 Million
Brief: Vicore Pharma And HealthCap Create Drug Development Company Focused On Severe Lung Diseases
Brief: Vicore Pharma Holding Q1 Operating Loss Widens To SEK 4.2 Million
Brief: Vicore Pharma Receives Approval To Start Phase IIa Study
Brief: Vicore Pharma: I-Tech Enters Agreement With Chugoko Marine Paint